About Nucleus Global
Nucleus Global is a Healthcare company based in London (United Kingdom) founded in 1992 by Stephen Cameron, and was acquired by Huntsworth in November 2020. Consulting and communications services are provided in the medical sector. It operates on a Professional Services model. The company has 1,340 employees. Its chief executive, as recorded, is Stephen Cameron. Nucleus Global offers products and services including Medical Communications. Its focus areas include Medical Communications and Pharmaceutical Communications. Its legal entity is Nucleus Global Inc.
Company details
Strategic and innovative medical communications are provided by Nucleus Global for pharmaceutical, biotech, and medical device sectors. Services are tailored for medical affairs, scientific communications, and peer-to-peer promotional education teams. A science-first approach is integrated with digital, creative, and patient knowledge to ensure excellence. The focus is on delivering personalized solutions to clients in the healthcare industry.
- Headquarters London, United Kingdom
- Employees 1,340
- Founders Stephen Cameron
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website nucleus-global.com
- Social LinkedIn
- Acquired by Huntsworth (Nov 2020)
- Legal Name Nucleus Global Inc
- Annual Revenue$430.31 K (USD)23as on Dec 31, 2019
- Net Profit$734.21 K (USD)-90as on Dec 31, 2019
- EBITDA$944.89 K (USD)-86as on Dec 31, 2019
- Investors
- Employee Count1,340
- Acquired byHuntsworth
(Nov 2020)
Products & Services of Nucleus Global
Nucleus Global offers a comprehensive portfolio of products and services, including Medical Communications.
Medical communications are provided for pharmaceutical and biotech sectors.
Investors in Nucleus Global
Nucleus Global has secured backing from 1 investor. Prominent investors backing the company include Huntsworth.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Full-service film laboratory and digital dailies services are provided. | 1974 | huntsworth.com | London, United Kingdom |
Investor details for Nucleus Global
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Nucleus Global
1 people are tracked at Nucleus Global (1 in leadership); the tracked headcount is 1,340.
| Name | Role | Group |
|---|---|---|
Stephen Cameron | Founder & CEO | Leadership |
Complete people profiles for Nucleus Global
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Nucleus Global
2 dated milestones of Nucleus Global across 28 years, from founding to its latest funding, stage changes and deals.
- Founded Nucleus Global is founded.
- Exit Acquired by Huntsworth.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nucleus Global
Nucleus Global was founded in 1992.
Nucleus Global is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Stephen Cameron is the CEO of Nucleus Global, as recorded in our data. They have also founded this company.
Nucleus Global has 1,340 employees.
Annual revenue of Nucleus Global is $430.31K as on Dec 31, 2019.
Strategic and innovative medical communications are provided by Nucleus Global for pharmaceutical, biotech, and medical device sectors. Services are tailored for medical affairs, scientific communications, and peer-to-peer promotional education teams. A science-first approach is integrated with digital, creative, and patient knowledge to ensure excellence. The focus is on delivering personalized solutions to clients in the healthcare industry.
Nucleus Global offers Medical Communications.
Nucleus Global has 1 investor. Key investors include Huntsworth.
Nucleus Global operates through Nucleus Global Inc.
Yes. Nucleus Global was acquired by Huntsworth in November 2020.